NANOVIRICIDES, INC. - 8-K Filing
NanoViricides participated in the AGP Healthcare Companies Showcase on May 20, 2026. During a fireside chat, Dr. Anil R. Diwan discussed two drug candidates—NV-387 and NV-387 encapsulating Remdesivir—which are expected to be effective against the current Ebola virus Bundibugyo strain in DRC. (Items: 7.01 Regulation FD Disclosure)
Tickers: $NNVC